Connect with us

News

Women in England to get contraceptive pill from chemists under new NHS plans

The rollout is hoped to free up appointments and help improve access to general practice

Published

on

Women in England will be able to get the contraceptive pill at their local pharmacy from next month, without the need for a GP appointment.

Pharmacies will begin offering the new contraceptive service in December with almost half a million women able to access the pill next year without needing to contact their GP first.

For the first time across England, women will be able to walk into their local pharmacy to be supplied oral contraception and receive their next supply.

The rollout is part of the NHS and government’s primary care access recovery plan, hoped to free up appointments and help improve access to general practice.

As more pharmacies begin offering the contraceptive service, the government says the nhs.uk web page will be updated so women can check which pharmacy near to them is offering access to contraception.

Pharmacists will also ramp up the number of blood pressure checks given to at-risk patients over the next year which could prevent more than 1,350 heart attacks and strokes.

Amanda Pritchard, NHS chief executive, said: “The care and support people receive from their local pharmacy is rightly highly valued by patients and so it is essential we use the skills and convenience of community pharmacies to make it as easy as possible for people to get the help they need.

“This is really good news for women. We all lead increasingly busy lives and thanks to this action, rather than making a GP appointment, women can simply pop into their local pharmacy when they need or want to access contraception.”

Health and Social Care Secretary, Victoria Atkins, said: “For the public, these changes will mean more options for women when making a choice about their preferred contraception and reduce the risks of people suffering heart attacks and strokes.

“For healthcare professionals, this will free up GP appointments and make better use of the skills and expertise within community pharmacies.”

Dr Claire Fuller, NHS medical director for primary care and the NHS’ lead GP in England, said: “I’m delighted the changes that the NHS is making mean people will have new and convenient ways of accessing treatments for many common conditions.

“In particular, contraception is essential for many women, and this is a big step forward in making these services easier for women to access.

“Local pharmacies are trusted parts of our communities and GPs and pharmacists work closely together. Pharmacists have always provided continuity and long-term support to patients, families, and carers. So, this is a safe and common-sense way of making NHS services easier for patients to use.”

Janet Morrison, chief executive at Community Pharmacy England, added: “It makes perfect sense to use community pharmacies as a first port of call for healthcare advice, access to contraception and health checks.

“Local pharmacies are staffed by highly qualified healthcare professionals and empowering them to do more is a logical next step for primary care. These new services will help patients and the public, as well as reducing pressure on GPs and the wider NHS.”

William Pett, head of policy, public affairs and research at Healthwatch England, said: “Women across England will welcome the convenience of getting the contraceptive pill at a local pharmacy.

“Being able to see your GP in a timely manner remains the public’s top concern. If this initiative is effectively communicated and delivered, it will make a real difference to patients and relieve the pressure on hard-pressed services.”

However, he warned: “There could be potential problems, such as pharmacists not being able to see enough of people’s GP records or the ability of different communities and areas to access the new service. But, if evaluated well, the NHS will be able to ensure that this promising new service really works for patients.”

Tase Oputu, chair of the Royal Pharmaceutical Society’s English Pharmacy Board, said: “This move will provide women with greater choice in obtaining contraception and advice in the way that best meets their needs.

“Pharmacists are experts in medicines and perfectly placed to provide relevant health checks and ongoing support for women accessing contraception.

“The trials of this scheme showed a widespread welcome for the service and the convenience community pharmacy offers as the front door to the NHS. It also makes suitable use of the clinical skills of pharmacists in partnership with GPs and existing sexual health services.”

News

Menopause start-up bags US$60m in funding

Midi Health aims to expand access to insurance-covered care for women in midlife and beyond

Published

on

Midi Health Series B round investors and founders, pictured from left: GV Executive venture partner Cathy Friedman, Midi Health co-founder Kathleen Jordan, Midi Health co-founder Jill Herzig, Felicis Ventures general partner Victoria Treyger, Operator Collective founder Mallun Yen, Midi Health co-founder Sharon Meers, Midi Health co-founder and CEO Joanna Strober, Emerson Collective managing partner Fern Mandelbaum, SemperViren partner Allison Baum Gates, GV general partner Frederique Dame

The US menopause start-up Midi Health has secured US$60m in funding, bringing the company’s total funding raised to date to US$100m.

The funding round was led by Emerson Collective, with support from additional investors, including GV (Google Ventures), Memorial Hermann, SemperVirens, Felicis, Icon Ventures, Black Angel Group, Gingerbread Capital, Able Partners, G9 and Operator Collective.

They joined a syndicate of primarily female-led investors including F7, Steel Sky Ventures, Avestria, Muse Capital, 1843 Capital, Anne WojcickiSusan Wojcicki, and K50 Ventures.

Founded with a mission to close this care gap, Midi is now the fastest-growing virtual clinic focused on treating women in perimenopause and menopause.

The California start-up, which expanded to all 50 states in November, aims to help women navigating midlife hormonal changes.

The company provides patients with care plans that include hormonal and non-hormonal medications, supplements and lifestyle coaching and has partnerships with major healthcare systems, such as Memorial Hermann and benefits platforms, such as Progyny and Cleo.

The additional investment round is hoped to help Midi expand insurance coverage, hire and upskill an additional 150 clinicians, diversify service lines, amplify the conversation around women’s health and scale to care for over one million women per year by 2029.

“We started Midi with just one specific focus: helping women access world-class, expert perimenopause and menopause care, covered by insurance, and we have been at the forefront of delivering on that promise,” Joanna Strober, CEO and co-founder of Midi, explained.

“But what we have also learned is that addressing the health concerns of women in midlife is more complex than simply treating hot flashes and prescribing hormone replacement therapy.

“Midi takes a multi-symptom, holistic approach to care designed to help women live their best, most productive and fulfilling lives—whether that involves medication, lifestyle coaching, natural supplements, or other support.

“Our goal now is to expand services and scope to continue this comprehensive, personalised care far beyond menopause.”

Women spend more than a third of their lives in perimenopause or menopause, with more than one billion women globally expected to be in these life stages by 2030.

Upwards of 85 per cent of women will experience menopausal symptoms that can negatively impact their productivity and quality of life, yet 75 per cent of women who seek care for these symptoms do not receive any treatment.

The primary reason is that only about one in five OB/GYNs, and even fewer primary care physicians, receive specialised menopause education or training.

“Historically, women’s healthcare has been neglected, with perimenopause and menopause having significant unmet needs,” said Fern Mandelbaum of Emerson Collective.

“Midi is providing expert, empathetic care coupled with comprehensive insurance coverage, finally addressing this gap and ensuring that all women receive the support they need and deserve.”

To receive the Femtech World newsletter, sign up here.

Continue Reading

News

Start-up launches London Underground campaign to break down period stigma

The two-week campaign seeks to challenge societal taboos surrounding menstrual health

Published

on

The Irish women’s health start-up Riley has launched an ad campaign on the London Underground to “take the fear out of periods”.

Riley, an eco-friendly period product subscription service, aims to take action against period poverty and democratise access to period products.

The company seeks to encourage the introduction of menstrual health policies and foster a workplace where discussions around periods are normalised.

Its two-week London Underground campaign, which coincides with the opening of its first office in London, is hoped to help destigmatise periods and normalise conversations around menstrual health.

“The idea behind this campaign comes from the fact that free period care in the office is often seen as an employee perk or a ‘nice to have’, when it should actually be an essential offering in every office,” Meaghan Droney, eCommerce manager at Riley, told Femtech World.

“Our aim with this campaign is to flip those current mindsets and get people to change their attitudes towards period care in the workplace.

“With 79 per cent of menstruators feeling unsupported in relation to their periods at work, this oversight is clearly fundamentally unfair and it’s time for change.

“We’re encouraging any and all businesses to get in touch with us so we can support them in introducing menstrual policies and free period care in their workplace to empower all employees, no matter their gender, to thrive and feel valued at work.”

Research by the Chartered Institute of Personnel and Development (CIPD) shows that only 12 per cent of UK companies provide support for menstruation and menstrual health, despite 85 per cent of women experiencing stress or anxiety when managing their period at work.

Data suggests that half of the women who take absence because of their menstrual cycle feel unable to tell their manager, underscoring the deep-rooted stigma around periods.

Fiona Parfrey, co-founder of Riley, said: “Access to safe and high-quality sustainable period care products not only demonstrates a commitment to employee welfare but also fosters a culture of empathy, equality, and respect, ultimately contributing to a more engaged and empowered workforce.

“Menstrual policies and free period care are a fundamental necessity for every individual in the workplace. It’s about ensuring that employees have the resources they need to maintain their wellbeing and productivity without interruption.”

To receive the Femtech World newsletter, sign up here.

Continue Reading

News

Singapore-based fertility centre sets up grant for couples struggling to conceive

This grant aims to support eligible Singaporean couples facing financial and family planning challenges

Published

on

A Singapore-based fertility centre is to set up a grant to support couples struggling to conceive.

Virtus Fertility Centre Singapore (VFCS) announced that it would set up a grant to support aspiring parents on their IVF journey.

The initial grant is set for at $50,000 SGD and, depending on the take-up rate over the next 12 fiscal months, VFCS plans to increase the pool to benefit more couples in the subsequent years.

The grant will cover the main costs associated with IVF treatments and procedures, including embryo retrieval and transfer, laboratory services and embryo prep. It will also be applicable to fresh and frozen egg transfers.

As grant recipients, their samples will similarly be given a radio frequency identification (RFID) tag, a service VFCS provides for all its patients. It locks the patient’s identity with the respective sample. The RFID identifies gametes—eggs, sperms, or embryos—at every stage of the IVF treatment.

According to VFCS, the grant will also include access to counselling services and wellness resources.

“I’ve witnessed firsthand the emotional toll and occasional frustration that infertility can take on individuals and couples, especially for some who are still young and healthy,” said Dr Roland Chieng, medical director at VFCS.

“The common deterrent of going for fertility treatment is always associated with the cost, more so in a private care setting where their only source of funds is through Medisave.

“By alleviating their financial concerns, we hope ReadyBaby Fertility Grant empowers patients to approach their IVF journey, focusing on their clinical needs and working towards a healthy pregnancy and less on financials.

“With access to the necessary treatments and support, patients can embark on their path to parenthood with renewed confidence, knowing they have the clinical resources and guidance they need to navigate this journey,” he added.

Tim Kwan, VFCS’s managing director, said: “We believe every couple deserves the opportunity to experience the profound joy of parenthood.

“With the ReadyBaby Fertility Grant, we aim to support aspiring couples on their IVF journey and help them bring new life into the world.”

To be eligible for the grant, applicants must be married Singaporean couples diagnosed with medical infertility by a fertility specialist and first-time parents who have not tried IVF before.

To receive the Femtech World newsletter, sign up here.

Continue Reading

Trending

Copyright © 2023 Aspect Publishing Ltd. All Rights Reserved.